Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ana Esther Kerguelen Fuentes"'
Autor:
Rosario Torres, Aurora Viejo, Elena G Arias-Salgado, Víctor Jiménez-Yuste, Kapil Laxman Nanwani Nanwani, Dolores Hernández-Maraver, Miguel Canales, Mar Gutierrez, Elena Muñoz, Nora Butta, Ana Esther Kerguelen Fuentes, A. Martínez, Manuel Quintana, María Teresa Álvarez Román, Charbel Maroun
Publikováno v:
Blood. 136:6-7
Introduction: Trauma-induced coagulopathy (TIC) is a multifactorial condition secondary to severe trauma. In TIC, early fibrinogen (FI) replacement and low dose of recombinant activated factor VII (rFVIIa) may positively impact outcome. Factor XIII (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1766fedad9e5d9c141eb34d059c78d9f
https://doi.org/10.1182/blood-2020-142482
https://doi.org/10.1182/blood-2020-142482
Autor:
Miguel Ángel Canales Albendea, Luis Lombardia, Ana Esther Kerguelen Fuentes, Ana Rodríguez de la Rúa, Dolores Hernández-Maraver
Publikováno v:
Medicina Clínica. 139:373-378
Resumen Fundamento y objetivo La identificacion de la mutacion V617F del gen JAK2 en pacientes diagnosticados de neoplasias mieloproliferativas cronicas (NMPC) es fundamental en el cribado diagnostico. Nuestro objetivo fue investigar la asociacion en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aee99fd59470eaf9470f66410c73019d
https://doi.org/10.1016/j.medcli.2012.03.032
https://doi.org/10.1016/j.medcli.2012.03.032
Autor:
Ana Rodríguez de la Rúa, Miguel Angel, Canales Albendea, Dolores Hernández-Maraver, Ana Esther Kerguelen Fuentes
Publikováno v:
Blood. 120:5059-5059
Abstract 5059 JAK2 inhibitors are known to improve symptoms, to control myeloproliferation and to reduce splenomegaly in patients diagnosed with chronic myeloproliferative neoplasms (MPNs)Ph(-). However their ability to decrease the allele burden and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70f6903f150ac47c503bddd03ce39fb5
https://doi.org/10.1182/blood.v120.21.5059.5059
https://doi.org/10.1182/blood.v120.21.5059.5059